» Articles » PMID: 10454063

Incidence of Thyroid Cancer in Scandinavia Following Fallout from Atomic Bomb Testing: an Analysis of Birth Cohorts

Overview
Specialties Oncology
Public Health
Date 1999 Aug 24
PMID 10454063
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The occurrence relation between radioactive fallout from nuclear testing at Novaja Semlja in north-west Russia and the incidence of thyroid cancer in Norway and Sweden was studied following a birth cohort approach.

Methods: Birth cohorts with presumably different levels of exposure were identified according to calendar year of atomic tests and previous Norwegian estimates of the population dose (born 1947-1950 received low exposure in late childhood, born 1951-1962 received the highest exposure in early childhood, born 1963-1970 were not exposed). For each one-year birth cohort the incidence rates were calculated, with denominators based on exact population figures for each year of follow-up.

Results: In a stratified analysis, the relative risk for the highest exposed cohorts born 1951-1962, compared to those not exposed born 1963-1970, was found to decrease with increasing age from a borderline significant relative risk (RR) of 1.7 (95 percent confidence interval, 95% CI: 1.0-3.0) for children in the age-group 7-14 years to no excess risk among those 20-24 years of age (RR: 0.9; 95% CI: 0.7-1.2). The mean age at diagnosis of thyroid cancer in the age-group 7 14 years was lowest in the birth cohorts with the highest exposure. The Poisson regression analysis showed essentially the same results, with an improved fit when adding an interaction term between age and birth-cohort to a basic model with age, gender, birth-cohort and country.

Conclusion: These results are compatible with an increased risk of thyroid cancer during childhood and adolescence for subjects exposed to radioactive fallout early in life. Alternative explanations for the pattern of incidence are discussed.

Citing Articles

A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort.

Lerro C, Jones R, Langseth H, Grimsrud T, Engel L, Sjodin A Environ Res. 2018; 165:125-132.

PMID: 29698872 PMC: 5999553. DOI: 10.1016/j.envres.2018.04.012.


NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Berardinelli F, Di Masi A, Antoccia A Curr Genomics. 2014; 14(7):425-40.

PMID: 24396275 PMC: 3867719. DOI: 10.2174/13892029113146660012.


Interleukin 22 polymorphisms and papillary thyroid cancer.

Eun Y, Shin I, Lee Y, Shin S, Kim S, Chung J J Endocrinol Invest. 2013; 36(8):584-7.

PMID: 23448944 DOI: 10.3275/8879.


Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update.

Gilbert E, Huang L, Bouville A, Berg C, Ron E Radiat Res. 2010; 173(5):659-64.

PMID: 20426666 PMC: 3865880. DOI: 10.1667/RR2057.1.


RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O J Endocrinol Invest. 2008; 31(10):893-9.

PMID: 19092295 DOI: 10.1007/BF03346438.